Clinical Trials

NCT03588299 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2
11 participants
NCT02020070 | COMPLETED | PHASE2
16 participants

Combining Ipilimumab, Degarelix, and Radical Prostatectomy in Men With Newly Diagnosed Metastatic Castration Sensitive Prostate Cancer or Ipilimumab and Degarelix in Men With Biochemically Recurrent Castration Sensitive Prostate Cancer After Radical Prostatectomy

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-06
Start Date:
2013-12-18
Completion:
2026-06-30
Conditions
  • Metastatic Castration Sensitive Prostate Cancer
Interventions
  • DRUG
  • PROCEDURE
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page